Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24,457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Genovese MC, Durez P, Richards HB, Supronik J, Dokoupilova E, Mazurov V, Aelion JA, Lee SH, Codding CE, Kellner H, Ikawa T, Hugot S, Mpofu S. Genovese MC, et al. Among authors: lee sh. Ann Rheum Dis. 2013 Jun;72(6):863-9. doi: 10.1136/annrheumdis-2012-201601. Epub 2012 Jun 23. Ann Rheum Dis. 2013. PMID: 22730366 Clinical Trial.
One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study.
Genovese MC, Durez P, Richards HB, Supronik J, Dokoupilova E, Aelion JA, Lee SH, Codding CE, Kellner H, Ikawa T, Hugot S, Ligozio G, Mpofu S. Genovese MC, et al. Among authors: lee sh. J Rheumatol. 2014 Mar;41(3):414-21. doi: 10.3899/jrheum.130637. Epub 2014 Jan 15. J Rheumatol. 2014. PMID: 24429175 Clinical Trial.
A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study.
Bae SC, Kim J, Choe JY, Park W, Lee SH, Park YB, Shim SC, Lee SS, Sung YK, Choi CB, Lee SR, Park H, Ahn Y; HERA Study Investigators. Bae SC, et al. Among authors: lee sh, lee sr, lee ss. Ann Rheum Dis. 2017 Jan;76(1):65-71. doi: 10.1136/annrheumdis-2015-207613. Epub 2016 Feb 23. Ann Rheum Dis. 2017. PMID: 26905864 Clinical Trial.
Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months.
Bae SC, Cho SK, Won S, Lee HS, Lee SH, Kang YM, Lee SH, Lee YA, Choe JY, Chung WT, Suh CH, Shim SC, Lee J, Yoon BY, Kim DW, Lee SS, Yoo WH, Kim JS, Jung YO, Nah SS, Lee CK, Song GG, Choi SJ, Joung CI, Koh H, Kim YJ. Bae SC, et al. Among authors: lee sh, lee ya, lee ck, lee hs, lee j, lee ss. Int J Rheum Dis. 2018 May;21(5):1001-1009. doi: 10.1111/1756-185X.12915. Epub 2016 Nov 5. Int J Rheum Dis. 2018. PMID: 29878615
Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study.
Park MC, Matsuno H, Kim J, Park SH, Lee SH, Park YB, Lee YJ, Lee SI, Park W, Sheen DH, Choe JY, Choi CB, Hong SJ, Suh CH, Lee SS, Cha HS, Yoo B, Hur JW, Kim GT, Yoo WH, Baek HJ, Shin K, Shim SC, Yang HI, Kim HA, Park KS, Choi IA, Lee J, Tomomitsu M, Shin S, Lee J, Song YW. Park MC, et al. Among authors: lee sh, lee si, lee j, lee yj, lee ss. Arthritis Res Ther. 2019 May 21;21(1):122. doi: 10.1186/s13075-019-1910-2. Arthritis Res Ther. 2019. PMID: 31113455 Free PMC article. Clinical Trial.
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3).
Tanaka Y, Takeuchi T, Tanaka S, Kawakami A, Iwasaki M, Song YW, Chen YH, Wei JC, Lee SH, Rokuda M, Izutsu H, Ushijima S, Kaneko Y, Akazawa R, Shiomi T, Yamada E. Tanaka Y, et al. Among authors: lee sh. Ann Rheum Dis. 2019 Oct;78(10):1320-1332. doi: 10.1136/annrheumdis-2019-215163. Epub 2019 Jul 26. Ann Rheum Dis. 2019. PMID: 31350270 Free PMC article. Clinical Trial.
Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines.
Hur JW, Choe JY, Kim DW, Kim HA, Kim SH, Kim WU, Kim YS, Lee HS, Lee SH, Park SH, Park W, Park YB, Suh CH, Shim SC, Song YW, Yoon BY, Yu DY, Yoo DH. Hur JW, et al. Among authors: lee sh, lee hs. Rheumatol Int. 2015 Nov;35(11):1817-23. doi: 10.1007/s00296-015-3353-7. Epub 2015 Sep 5. Rheumatol Int. 2015. PMID: 26342296
24,457 results
You have reached the last available page of results. Please see the User Guide for more information.